Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) EBT (2016 - 2025)

Historic EBT for Alkermes (ALKS) over the last 16 years, with Q3 2025 value amounting to $100.7 million.

  • Alkermes' EBT fell 860.47% to $100.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $401.0 million, marking a year-over-year increase of 2070.73%. This contributed to the annual value of $443.8 million for FY2024, which is 527.4% up from last year.
  • Per Alkermes' latest filing, its EBT stood at $100.7 million for Q3 2025, which was down 860.47% from $104.8 million recorded in Q2 2025.
  • In the past 5 years, Alkermes' EBT registered a high of $281.8 million during Q2 2023, and its lowest value of -$67.4 million during Q3 2022.
  • Its 5-year average for EBT is $60.7 million, with a median of $58.3 million in 2023.
  • In the last 5 years, Alkermes' EBT tumbled by 131053.83% in 2021 and then surged by 94760.6% in 2023.
  • Over the past 5 years, Alkermes' EBT (Quarter) stood at $127.3 million in 2021, then dropped by 10.04% to $114.5 million in 2022, then plummeted by 49.06% to $58.3 million in 2023, then skyrocketed by 191.32% to $169.9 million in 2024, then crashed by 40.7% to $100.7 million in 2025.
  • Its EBT was $100.7 million in Q3 2025, compared to $104.8 million in Q2 2025 and $25.5 million in Q1 2025.